PHVS Pharvaris N.V.

NEUTRAL Impact: 4/10 Insider Cluster (3 insiders)
Horizon days Filed Apr 30, 2026 Processed 15d 3h ago
Insider cluster: 3 insiders, $1.4M total
Latest settled — T+5d
PHVS ▼ -2.90% at T+5d
NEUTRAL call ✗ call lost -2.90% · α vs SPY -4.63% · entry $31.01 → $30.11
Next anchor: T+20d in 8d
Currently $29.45 · -5.03% from $31.01 entry
Entry anchored
Apr 29, 03:59 PM ET
via Databento tick
T+1d
-5.06%
call -5.06% · α -5.28%
$29.44
settled 20d ago
T+5d
-2.90%
call -2.90% · α -4.63%
$30.11
settled 14d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Three Pharvaris insiders (CMO, Chief Early Development, Director) sold a combined ~$2.19M in open-market transactions over the past week, representing 0.11% of market cap. Sales are modest relative to company size but involve senior officers, warranting monitoring.

Key Financial Metrics

Direction
selling
Total Value
$2.2M
Insiders
3

Actionable Insight

Monitor for upcoming clinical catalysts or regulatory updates, as the selling is small but involves key executives. Any further insider sales could amplify bearish sentiment.

Key Facts

  • Lu Peng (CMO) sold ~$989K across three separate trades.
  • Lesage Anne (Chief Early Development) sold ~$223K in two trades.
  • Schikan Johannes (Director) sold ~$976K in two trades.
  • Total open-market sales: ~$2.19M (0.11% of $2.0B market cap).
  • All sales were preceded by option exercises at nominal prices, typical for tax or profit-taking.

Financial Impact

$2.19 million in insider sales over 7 days

Risk Factors

  • Continued insider selling may signal low confidence ahead of news.
  • No clear catalyst identified—selling may be pre-planned or tax-related.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1778010710838
18 reports for PHVS
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+20▲ +11.42%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
Type Now
May 20, 2026
today
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+5
May 20, 2026
today
144
NEUTRAL ★ 2/10
awaiting T+5
May 19, 2026
1d ago
Insider Cluster
NEUTRAL ★ 4/10
awaiting T+5
May 12, 2026
8d ago
Press Release
NEUTRAL ★ 5/10
$32.94 $28.95▼ −12.11%▼ −10.95%$29.45 (−10.60%)
May 11, 2026
9d ago
6-K
NEUTRAL ★ 4/10
$31.25 $28.81▼ −7.81%▼ −7.89%$29.45 (−5.76%)
May 11, 2026
9d ago
Press Release
NEUTRAL ★ 5/10
$31.25 $28.81▼ −7.81%▼ −7.89%$29.45 (−5.76%)
May 8, 2026
12d ago
424B5
NEUTRAL ★ 4/10
$29.95 $28.81▼ −3.81%▼ −3.72%$29.45 (−1.67%)
May 8, 2026
12d ago
Press Release
BEARISH ★ 6/10
$30.09 $30.70▼ −2.03%▼ −0.56%$29.45 (+2.13%)
Apr 30, 2026
20d ago
Insider Cluster
NEUTRAL ★ 4/10
$31.01 $30.11▼ −2.90%▼ −4.63%$29.45 (−5.03%)
Apr 23, 2026
27d ago
Insider Cluster
NEUTRAL ★ 2/10
$27.29 $31.01▲ +13.63%▲ +12.15%$29.45 (+7.91%)
Showing 10 of 18

US Market Status

Market Closed — Opens Thu (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access